http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002275156-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ead90443277482e25bf91bfddef2b5a7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
filingDate 2001-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f936ba0be41d879b239a85a5df91773e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac045a488a2cd0e7c49f06f5b4ae6c3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e5ded0cdddce900d599e7ca16b2673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d840dcf1fc595b1b04374ede570081
publicationDate 2002-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2002275156-A
titleOfInvention Method for producing 1,4-dihydropyridine monoester derivative
abstract PROBLEM TO BE SOLVED: To obtain an asymmetric 1,4-dihydropyridine-3,5-dicarboxylic acid diester having a blood pressure lowering action and a vasodilator action in high purity. SOLUTION: The following formula (I): (Wherein, Ar represents an aryl group which may have a substituent, and R 1 and R 2 independently represent an alkyl group having 6 or less carbon atoms). By decomposition, 1,4-dihydropyridine in which one R 1 is replaced by H In producing the 3,5-dicarboxylic acid monoester derivative, 0.8 to 2.0 moles of a metal hydroxide catalyst, 10 to 50 moles of water and 1 to 20 times by weight of diesters are used as OH groups per mole of diesters. The reaction is performed in the presence of a polar organic solvent.
priorityDate 2001-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12218865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420001195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449102014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407458795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226889149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457460012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415786448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22322686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450282151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16722120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140361370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410562037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415746651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452458000

Total number of triples: 47.